Lei Lu, Senior Vice President, Finance and Accounting, most recently served as Executive Vice President, Finance for HUYABIO, where he was responsible for leading financial strategy, FP&A, tax, treasury, and accounting operations. Prior to HUYABIO, he was Senior Vice President, Finance at ACEA Therapeutics (acquired by Sorrento Therapeutics) and ACEA Biosciences (acquired by Agilent). He holds a BA in economics from Capital University of Economics and Business, and an MBA from Katholieke Universiteit Leuven.
